These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29079218)

  • 1. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.
    Tibrewal S; Duell PB; DeBarber AE; Loh AR
    J AAPOS; 2017 Dec; 21(6):505-507. PubMed ID: 29079218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign.
    Monson DM; DeBarber AE; Bock CJ; Anadiotis G; Merkens LS; Steiner RD; Stout AU
    Arch Ophthalmol; 2011 Aug; 129(8):1087-8. PubMed ID: 21825196
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts.
    Fernández-Eulate G; Martin GC; Dureau P; Speeg-Spatz C; Brassier A; Gillard P; Bremond-Gignac D; Thouvenin D; Pagan C; Lamari F; Nadjar Y
    Orphanet J Rare Dis; 2022 Dec; 17(1):434. PubMed ID: 36514115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
    Preiss Y; Santos JL; Smalley SV; Maiz A
    Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.
    Stelten BML; Bonnot O; Huidekoper HH; van Spronsen FJ; van Hasselt PM; Kluijtmans LAJ; Wevers RA; Verrips A
    J Inherit Metab Dis; 2018 Jul; 41(4):641-646. PubMed ID: 28894950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
    Salen G; Steiner RD
    J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous xanthomatosis.
    Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
    J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].
    Blaabjerg M; Marjanovic D
    Ugeskr Laeger; 2013 Jan; 175(5):285-6. PubMed ID: 23369332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis.
    Yunisova G; Tufekcioglu Z; Dogu O; Bilgic B; Kaleagasi H; Akca Kalem S; Lohmann E; Gurvit HI; Emre M; Hanagasi HA
    Neurodegener Dis; 2019; 19(5-6):218-224. PubMed ID: 32349000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and follow-up of children with cerebrotendinous xanthomatosis.
    van Heijst AF; Verrips A; Wevers RA; Cruysberg JR; Renier WO; Tolboom JJ
    Eur J Pediatr; 1998 Apr; 157(4):313-6. PubMed ID: 9578968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis for cerebrotendinous xanthomatosis with juvenile cataract and family history.
    Öncel Acır N; Taskiran Kandeger B
    Ophthalmic Genet; 2023 Aug; 44(4):361-365. PubMed ID: 37017268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of cerebrotendinous xanthomatosis].
    Koyama S; Kato T
    Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenile cataract: consider cholestanol.
    Tészás A; Pfund Z; Morava E; Kosztolányi G; Sistermans E; Wevers RA; Kellermayer R
    Arch Ophthalmol; 2006 Oct; 124(10):1490-2. PubMed ID: 17030721
    [No Abstract]   [Full Text] [Related]  

  • 19. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.
    Mandia D; Chaussenot A; Besson G; Lamari F; Castelnovo G; Curot J; Duval F; Giral P; Lecerf JM; Roland D; Pierdet H; Douillard C; Nadjar Y
    J Neurol; 2019 Aug; 266(8):2043-2050. PubMed ID: 31115677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.